- Results are currently sorted by relevance (Sort results by: date)
- Results 1 - 10 (of 867)
Degarelix (Firmagon) induction and maintenance...releasing hormone (LHRH) agonists, degarelix (Firmagon) is a LHRH antagonist that...month. The pivotal phase III study of degarelix (CS21) in 610 patients reported non...
29 October 2013 - Publisher: London Cancer New Drugs Group - Publication type: Evidence summaries
Degarelix for advanced hormone dependent prostate...clinical trial has demonstrated that degarelix reduces testosterone to similar levels...testosterone levels upon initiation of degarelix therapy, unlike the situation that occurs...
05 October 2011 - Publisher: Peninsula Health Technology Commissioning Group - Publication type: Drug Specific Review
AWMSG issues Final Appraisal Report on degarelix (Firmagon®) for treatment of advanced hormone-dependent prostate cancer
...Strategy Group Final Appraisal Report Degarelix (Firmagon ® ) – December 2009 Page 1 of 24 Final Appraisal Report Degarelix (Firmagon® ) for the treatment of...December 2009 Recommendation of AWMSG Degarelix (Firmagon® ) is not recommended...
04 February 2010 - Publisher: All Wales Medicines Strategy Group (AWMSG) - Publication type: Drug Specific Review
...company presented details about Firmagon (degarelix) at the European Association of Urology...study period. The data also shows that degarelix suppresses testosterone and PSA faster...Sheffield, noted that unlike LHRH agonists, degarelix does not induce an initial testosterone surge...
23 March 2009 - Publisher: PharmaTimes - Publication type: News - News
The efficacy and safety of degarelix, a GnRH antagonist: a 12-month, multicentre, randomized, maintenance dose-finding phase II study in Japanese patients with prostate cancer.
... Title The efficacy and safety of degarelix, a GnRH antagonist: a 12-month...To assess the efficacy and safety of degarelix, a new gonadotropin-releasing hormone...prostate (any stage) were treated. Degarelix was administered subcutaneously at an...
Cochrane Central Register of Controlled Trials, John Wiley & Sons Ltd, 01 June 2012 - Publisher: Japanese journal of clinical oncology
...composition Each vial contains 80 mg degarelix (as acetate). After reconstitution...ml of solution contains 20 mg of degarelix. For the full list of excipients... The therapeutic effect of degarelix should be monitored by clinical parameters...
19 December 2013 - Publisher: electronic Medicines Compendium - Publication type: Drug prescribing
...j.clinthera.2009.11.009. Degarelix: a gonadotropin-releasing hormone...available on the newly approved drug degarelix for use in treating prostate cancer...1970-November 2008) using the terms degarelix and FE200486; follow-up searches using...
02 January 2009 - Publisher: Elsevier - Publication type: Systematic Reviews
...advanced, hormone dependent) - degarelix depot [ID590]> Prostate cancer (advanced, hormone dependent) - degarelix depot: appraisal consultation document...advanced, hormone dependent) - degarelix depot: appraisal consultation document...
06 January 2014 - Publisher: National Institute for Health and Care Excellence - Publication type: Press and media
...general > Treatment > Cancer drugs > Degarelix (Firmagon) What is cancer Tests Treatment Cancer drugs Degarelix Chemotherapy Radiotherapy...answers Causes and symptoms Degarelix (Firmagon) This page tells...
CancerHelp UK, 11 July 2013
...therapies > Individual hormonal therapies > Degarelix (Firmagon ®) Cancer treatment ...Bicalutamide Buserelin Cyproterone Degarelix Diethylstilbestrol Exemestane...out how we produce our information| Degarelix (Firmagon ®) This information is...
Macmillan Cancer Support, 01 May 2012